Is it time to retire efavirenz as a first-line option worldwide? COMMENT

被引：0
|
作者：
Guanira, Juan, V [1 ]
Fichtenbaum, Carl J. [2 ]
机构：
[1] Inst Med Salud INMENSA, Lima, Peru
[2] Univ Cincinnati, Div Infect Dis, Coll Med, 231 Albert Sabin Way,POB 670560, Cincinnati, OH 45267 USA
来源：
AIDS | 2022年 / 36卷 / 02期
关键词：
D O I：
10.1097/QAD.0000000000003101
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：317 / 318
页数：2
相关论文
共 50 条
  • [1] Efavirenz - Still first-line king?
    Best, Brookie M.
    Goicoechea, Miguel
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2008, 4 (07) : 965 - 972
  • [2] Has the time come to abandon efavirenz for first-line antiretroviral therapy?
    Raffi, Francois
    Pozniak, Anton L.
    Wainberg, Mark A.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (07) : 1742 - 1747
  • [3] Cabozantinib: a new first-line option for papillary renal cell carcinoma? Comment
    Borchiellini, Delphine
    Barthelemy, Philippe
    LANCET, 2021, 397 (10275): : 645 - 647
  • [4] A confirmed first-line option for CLL
    Rebecca Kirk
    Nature Reviews Clinical Oncology, 2011, 8 (5) : 253 - 253
  • [5] Surgery as a first-line option for prolactinomas
    Mamelak, Adam
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2022, 17 (06) : 485 - 498
  • [6] Amisulpride: A first-line option in the management of schizophrenia
    不详
    Drugs & Therapy Perspectives, 2002, 18 (7) : 1 - 4
  • [7] Varenicline: A First-Line Treatment Option for Smoking Cessation
    Garrison, Gina Daubney
    Dugan, Sara E.
    CLINICAL THERAPEUTICS, 2009, 31 (03) : 463 - 491
  • [8] Pelvic/Perineal Reconstruction: Time to Consider the Anterolateral Thigh Flap as a First-line Option?
    Perrault, David
    Kin, Cindy
    Wan, Derrick C.
    Kirilcuk, Natalie
    Shelton, Andrew
    Momeni, Arash
    PLASTIC AND RECONSTRUCTIVE SURGERY-GLOBAL OPEN, 2020, 8 (04)
  • [9] Immunotherapy Beyond First-Line in NSCLC, Still An Option
    Modrego, A.
    Bote, H.
    Jimenez-Aguilar, E.
    Ponce-Aix, S.
    Zugazagoitia, J.
    Baena, J.
    Mazarico, J. M.
    Nunez, J. A.
    Iglesias, L. C.
    Paz-Ares, L.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S354 - S355
  • [10] Another option for first-line treatment of partial epilepsy?
    Abou-Khalil, Bassel W.
    LANCET NEUROLOGY, 2012, 11 (07): : 568 - 569
12345